webinar

The ADHD Omega Fatty Acid Connection – Bringing ADHD into Focus

December 2nd, 2020
Blog webinar
The ADHD Omega Fatty Acid Connection – Bringing A...

ADHD affects nearly 6.1 million children in the U.S. Incidence is 11% and growing in children aged 4 to 17 years of age — and an estimated 50% of those cases may persist into adulthood. ADHD and related conditions have traditionally been managed with pharmacotherapy, behavioral therapy, or a combination of the two. However, up to 30% of patients do not respond to stimulant medications, and there are concerns and controversies surrounding the side effects and long-term safety of such drugs.

Research over the past 40 years has shown that children with ADHD have significantly lower levels of essential fatty acids in their brains. Due to genetic differences in the way they metabolize dietary fats, they are not able to rebalance this from the diet alone. These deficiencies are thought to affect cell membrane structure and integrity, which in turn affects the regulation of crucial signaling molecules and inflammatory pathways in the brain.

In this webinar, you’ll:

  • Understand the prevalence of neurodevelopmental disorders with a special focus on ADHD
  • Learn about the ‘neurodiversity’ paradigm and self-empowerment: a strength-based approach
  • Gain insights into an inclusive approach to treatment, covering traditional, lifestyle, and nutritional interventions.
  • Be introduced to EQUAZEN® PRO and review the practical applications of this medical food designed to address differences in omega-fatty acid metabolism in children and adolescents with ADHD.†

Additional Resources

1 Comment

Add comment

Fullscript content philosophy

At Fullscript, we are committed to curating accurate, and reliable educational content for practitioners and patients alike. Our educational offerings cover a broad range of topics related to integrative medicine, such as supplement ingredients, diet, lifestyle, and health conditions.

Medically reviewed by expert practitioners and our internal Integrative Medical Advisory team, all Fullscript content adheres to the following guidelines:

  1. In order to provide unbiased and transparent education, information is based on a research review and obtained from trustworthy sources, such as peer-reviewed articles and government websites. All medical statements are linked to the original reference and all sources of information are disclosed within the article.
  2. Information about supplements is always based on ingredients. No specific products are mentioned or promoted within educational content.
  3. A strict policy against plagiarism is maintained; all our content is unique, curated by our team of writers and editors at Fullscript. Attribution to individual writers and editors is clearly stated in each article.
  4. Resources for patients are intended to be educational and do not replace the relationship between health practitioners and patients. In all content, we clearly recommend that readers refer back to their healthcare practitioners for all health-related questions.
  5. All content is updated on a regular basis to account for new research and industry trends, and the last update date is listed at the top of every article.
  6. Potential conflicts of interest are clearly disclosed.
Read more
Send this to a friend